We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-9.7%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$1.22B
AUM Growth
-$882M
Cap. Flow
-$698M
Cap. Flow %
-57.3%
Top 10 Hldgs %
37.48%
Holding
87
New
26
Increased
14
Reduced
19
Closed
26

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$50.4M
2
ABBV icon
AbbVie
ABBV
+$47.5M
3
HRTX icon
Heron Therapeutics
HRTX
+$46.7M
4
CAH icon
Cardinal Health
CAH
+$45.6M
5
BDX icon
Becton Dickinson
BDX
+$38.3M

Top Sells

Rank Stock Value
1
BOLD
Audentes Therapeutics, Inc
BOLD
+$73.8M
2
NVRO
NEVRO CORP.
NVRO
+$67.8M
3
ZBH icon
Zimmer Biomet
ZBH
+$66.3M
4
GILD icon
Gilead Sciences
GILD
+$55.2M
5
AGN
Allergan plc
AGN
+$53.8M

Sector Composition

Rank Sector Weight
1 Healthcare 84.43%
2 Technology 3.14%
3 Consumer Discretionary 1.97%
4 Industrials 0.46%
5 Utilities 0.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNC icon
26
Centene
CNC
$31.7B
$18.3M 1.5%
307,441
-511,788
-62% -$31.1M
MOH icon
27
Molina Healthcare
MOH
$10B
$17.4M 1.43%
124,444
-52,520
-30% -$7.03M
IQV icon
28
IQVIA
IQV
$38.3B
$17M 1.39%
157,201
-186,366
-54% -$26.6M
HCA icon
29
HCA Healthcare
HCA
$88.5B
$16.7M 1.37%
185,849
-93,562
-33% -$12.1M
NVDA icon
30
NVIDIA
NVDA
$5.3T
$16.3M 1.34%
2,473,680
+878,120
+55% +$5.54M
MSFT icon
31
Microsoft
MSFT
$3.71T
$15M 1.23%
95,177
+23,810
+33% +$3.92M
IMMU
32
DELISTED
Immunomedics Inc
IMMU
$14.3M 1.18%
1,064,041
-435,198
-29% -$7.32M
RETA
33
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$14.1M 1.16%
+97,864
New +$18.9M
BABA icon
34
Alibaba
BABA
$304B
$13.6M 1.12%
70,083
+25,672
+58% +$5.36M
ICLR icon
35
Icon
ICLR
$12.4B
$12.6M 1.03%
92,446
-101,131
-52% -$16.2M
SAGE
36
DELISTED
Sage Therapeutics
SAGE
$12.5M 1.03%
+436,477
New +$25.3M
RCUS icon
37
Arcus Biosciences
RCUS
$3.56B
$11.2M 0.92%
+809,511
New +$10.1M
HALO icon
38
Halozyme
HALO
$10.2B
$11.1M 0.91%
618,726
+25,246
+4% +$479K
AMZN icon
39
Amazon
AMZN
$2.94T
$10.4M 0.86%
+106,840
New +$10.3M
CNST
40
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$9.93M 0.82%
+315,894
New +$11M
XLNX
41
DELISTED
Xilinx Inc
XLNX
$9.72M 0.8%
+124,677
New +$10.9M
IGMS
42
DELISTED
IGM Biosciences
IGMS
$9.16M 0.75%
+163,105
New +$7.15M
ALNY icon
43
Alnylam Pharmaceuticals
ALNY
$28.9B
$8.9M 0.73%
+81,804
New +$9.44M
PPD
44
DELISTED
PPD, Inc. Common Stock
PPD
$8.51M 0.7%
+477,743
New +$12M
DCPH
45
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$8.49M 0.7%
+206,336
New +$11.5M
CHRS icon
46
Coherus Oncology
CHRS
$194M
$7.69M 0.63%
474,055
-61,031
-11% -$1.13M
LAB icon
47
Standard BioTools
LAB
$313M
$6.79M 0.56%
2,673,090
-561,894
-17% -$1.85M
IMMU
48
CALL
DELISTED
Immunomedics Inc
IMMU
$6.04M 0.5%
+447,700
New +$7.53M
DE icon
49
Deere & Co
DE
$166B
$5.55M 0.46%
+40,208
New +$6.36M
XLRN
50
DELISTED
Acceleron Pharma
XLRN
$5.52M 0.45%
+61,400
New +$4.77M
1
2
3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
PWA
Pitcairn Wealth Advisors Conshohocken, Pennsylvania $1.09B AUM

PFM Health Sciences's Q1 2020 Portfolio in Review

As of Q1 2020, PFM Health Sciences held 87 positions worth $1.22B, down 42% from $2.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

PFM Health Sciences withdrew a net $698M in Q1 2020, closing 26 positions and reducing 19 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $73.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 70% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PFM Health Sciences opened a new position in McKesson worth $46.5M.

  • PFM Health Sciences's largest Q1 2020 buy was McKesson: 343,950 shares worth $46.5M.
  • PFM Health Sciences added most to AbbVie in Q1 2020, an estimated $47.5M increase.
  • PFM Health Sciences's biggest Q1 2020 reduction was Gilead Sciences, cutting an estimated $55.2M.
  • PFM Health Sciences fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $73.8M.
  • PFM Health Sciences's ten largest holdings make up 37% of its $1.22B portfolio in Q1 2020.
  • PFM Health Sciences opened 26 new positions and closed 26 in Q1 2020.
  • PFM Health Sciences's portfolio value fell 42% quarter-over-quarter to $1.22B.

Based on PFM Health Sciences's 13F filing for Q1 2020, filed 15 May 2020.